1. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomized controlled trial;IST-3 Collaborative Group;Lancet,2012
2. Thrombolysis for acute ischaemic stroke;Wardlaw;Cochrane Database Syst. Rev,2009
3. Thrombolytic therapy of SM-9527 (duteplase; rt-PA) in hyperacute embolic stroke—the clinical efficacy and safety of thrombolytic agent in a randomized double-blind study;Kikuchi;Clin Eval,1994
4. Chen Q, He M. Intravenous thrombolysis with urokinase for acute cerebral infarction. The study group of a 5 year National Project of the People's Republic of China. In: Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy; May 27-28, 2002; Lyon, France.
5. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke;Hacke;N Engl J Med,2008